ArticleJMIR research protocols2025
Monitoring of Pregnant Women Using the "Risk Identification, Evaluation Counseling, Systematic Monitoring, Troubleshooting" (REST) Mobile App: Protocol for a Cluster Randomized Controlled Trial.
Article in JMIR research protocols, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05741931 (Monitoring Pregnant Women Using REST Mobile Application), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Monitoring Pregnant Women Using REST Mobile Application (Risk Identification, Evaluation Counseling, Systematic Monitoring, Troubleshooting)
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe maternal mortality rate (MMR) in Indonesia is still quite high and has not reached the national target. The success of maternal health programs can be assessed through the main indicator of the MMR. Pregnancy monitoring is one of the efforts to reduce the increase in the MMR.
objectiveThis study aims to improve maternal and child safety and health during pregnancy and childbirth through pregnancy monitoring using a mobile app called REST (Risk Identification, Evaluation Counseling, Systematic Monitoring, Troubleshooting).
methodsThe research used the cluster randomized controlled trial (RCT) design, involving pregnant women from 11 subdistricts in Purworejo Regency, who were randomized to 11 clusters in the intervention group and 11 clusters in the control group. The 22 ANC class clusters comprised 22 midwives and 220 pregnant women. The intervention group received monitoring using the REST mobile app, while the control group received standard pregnancy monitoring in the antenatal care (ANC) class. The mentoring program included the use of the REST mobile app, which consists of pregnancy checks according to the 10T pregnancy examination standard. The app was used by midwives and pregnant women, starting from the second trimester of pregnancy to childbirth.
resultsIn July 2023, the REST mobile app was prepared and tested in small community groups, including midwives and pregnant women, through simulation, and in September 2023, the app was further refined based on feedback from these groups and introduced to study participants. The majority of participants were aged 20-35 years (n=168, 76.4%), consistent with national demographic trends. Approximately 185 (84.1%) had secondary education (junior and senior high school), and 57 (25.9%) had tertiary education (college graduates). The participants were evenly distributed across economic quintiles, reflecting diverse socioeconomic backgrounds, and most lived approximately 1 km from a health facility. Ethical approval was obtained in April 2024. Staff training was conducted from July to October 2023. Participants were recruited from November 2023 to January 2024, the intervention was implemented from February to July 2024, and data were collected from August 2024 to February 2025. Data were analyzed in April 2025, and dissemination of results is expected by the end of 2025.
conclusionsPregnancy monitoring using the REST mobile app is expected to have a significant influence on the number of ANC visits, reduce pregnancy complications, improve normal delivery methods, and ensure the birth weight of the baby stays within normal limits (≥2500 g).
trial registrationClinicalTrials.gov NCT05741931; https://clinicaltrials.gov/study/NCT05741931. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/66774.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.